ARCHIVES

FDA Delays Decision On Avastin Approval For Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 34 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: NCI’s RAPID Program; RFA, Pas Avilable

May 14, 1999

Shubik Named To Another NCA Term In Surprise Move

June 25, 1976

NCI Committed To 50 Percent Mortality Reduction By 2000; DCPC Board Hears How That Will Be Done

January 20, 1984

FDA Approves Aranesp For Chemo-Induced Anemia

August 30, 2002

In Brief: Yarbro To Leave As NCI Centers Chief to Head Missouri Cancer Program; Replaced By Cantril

May 30, 1975

Wanted: Methods To Measure Or Estimate Renal Function For Dosing Cancer Drugs

October 15, 2010